|
|
Management
BG Medicine has assembled a world-class team of managers who each bring distinct industry and technology experience, a history of success, and a passion to succeed in their leadership roles. - Pieter Muntendam, M.D.
- President and CEO
- Michael W. Rogers
- Executive Vice President and CFO
- C. Douglas White
- Executive Vice President and General Manager, Diagnostics
- Neal Gordon, Ph.D.
- Senior Vice President, Biomarker Discovery
- Stacie Rader
- Senior Vice President, Executive Operations & Human Resources
- Carol A. Adiletto, M.S.
- Vice President, Clinical and Regulatory Affairs
- Aram Adourian, Ph.D.
- Vice President, Scientific Affairs
- Dr. Peter Gardiner
- Vice President, Medical Affairs & Chief Medical Officer
- Gregg Mayer
- Vice President, Diagnostic Strategy
- Rene Myers, Ph.D.
- Vice President, Strategic Alliances
-
Pieter Muntendam, M.D.
President and CEO
Pieter Muntendam, M.D., has President and CEO of BG Medicine since November 2004. He is a biopharmaceutical and healthcare executive with in-depth business experience ranging from early stage ventures to multinational corporations. Dr. Muntendam joined BG Medicine from NetNumina Solutions, Inc., a professional services company, where he served as Director of the Biopharma Healthcare Practice. Prior to joining NetNumina, he cofounded Vitivity Inc., a subsidiary of Millennium Pharmaceuticals, Inc., and served as Vice President of Medicine. Dr. Muntendam founded the health management firm ProMedex Inc. in 1996, where he served as President & Chief Executive Officer and chairman of the board until ProMedex was acquired by Landacorp, Inc. Prior to that, he served as Vice President of Care Management at Glaxo Wellcome (now GlaxoSmithKline). Dr. Muntendam held executive positions with Organon International Inc. and Johnson & Johnson where he was appointed Vice President of Research and Development, International at Johnson & Johnson, and appointed as a member of the boards of directors for two Johnson & Johnson operating companies. Dr. Muntendam received his M.D. from Leiden University in the Netherlands.
back to top
Michael W. Rogers
Executive Vice President and CFO
Michael W. Rogers joined BG Medicine in July 2009 as Executive Vice President, Chief Financial Officer and Treasurer. Prior to joining BG Medicine, Mr. Rogers held the position of Executive Vice President, Chief Financial Officer and Treasurer, at Indevus Pharmaceuticals, Inc. Mr. Rogers was Executive Vice President and Chief Financial and Corporate Development Officer at Advanced Health Corporation, a publicly-traded healthcare information technology company. He also served as Vice President, Chief Financial Officer and Treasurer, of AutoImmune, Inc., a publicly-traded biopharmaceutical company. Prior to his tenure at AutoImmune, Inc., Mr. Rogers was Vice President, Investment Banking, at Lehman Brothers, Inc., and was also associated with PaineWebber, Inc., serving most recently as Vice President, Investment Banking Division. Mr. Rogers received an M.B.A. from the Darden School at the University of Virginia and a B.A. from Union College.
back to top
C. Douglas White
Executive Vice President and General Manager, Diagnostics
Douglas White joined BG Medicine in February 2009 as Executive Vice President and General Manager of Diagnostics. Mr. White has 24 years of experience in the in vitro diagnostics market serving in multiple senior executive roles. His roles have included the leadership and development of markets and commercial organizations at Digene, Bayer, and Chiron Diagnostics. Prior to joining BG Medicine, Mr. White was Senior Vice President of Sales and Marketing, Americas, and Chair of the Americas Management Counsel at QIAGEN. During his tenure at Digene, Mr. White served as the Senior Vice President of Commercial Operations, where he was responsible for all commercial activities in the Americas and Asia Pacific in addition to the global product management organization. Prior to that Mr. White held several executive positions in the diagnostic industry, including Vice President of U.S. Sales and Marketing, Vice President of Global Product Management, Nucleic Acid Diagnostics, at Bayer Diagnostics, Vice President, Marketing, for Chiron Diagnostics, and served in several different management roles in sales, market development, and strategic and tactical marketing through his career at Chiron and Abbott Diagnostics. Mr. White has a B.A. in Political Science from Washington College.
back to top
Neal Gordon, Ph.D.
Senior Vice President, Biomarker Discovery
Neal F. Gordon, Ph.D., joined BG Medicine in January 2009 as Senior Vice President of Biomarker Discovery. Dr. Gordon has 20 years of experience in the biotechnology industry, serving both as a senior executive and in product development. Prior to joining BG Medicine, Dr. Gordon was President of Epitome Biosystems, where he spearheaded the development and subsequent market introduction of a line of multiplexed protein immunoassay products. Dr. Gordon also served as Senior Vice President of Manufacturing Operations at Antigenics Inc. Prior to Antigenics, Dr. Gordon spent ten years at PerSeptive Biosystems, which is now part of Life Technologies, Inc. as part of the founding technology team. Prior to his tenure at PerSeptive Biosystems, Dr. Gordon was a product development engineer at Proctor & Gamble. Dr. Gordon obtained a bachelor's degree in chemical engineering from McGill University and a Ph.D. in biochemical engineering from Massachusetts Institute of Technology.
back to top
Stacie Rader
Senior Vice President, Executive Operations & Human Resources
Prior to joining BG Medicine, Ms. Rader was Vice President at Flagship Ventures and Vice President, Human Resources, of NewcoGen since 1999. During her tenure with Flagship, she has consulted with numerous portfolio entities on HR operational issues. Ms. Rader has particular expertise in team building, staffing, and organizational development as well as compensation and benefits design and implementation. Prior to Flagship Ventures, she was Corporate Director of Worldwide Employment and Staffing for Applera Corporation (now Applied Biosystems) following the merger of Perkin Elmer and PerSeptive Biosystems in 1998. Ms. Rader was responsible for all human resources functions at PerSeptive from 1992 to 1998. During this period, she oversaw the hiring of 600 global employees and the implementation of core HR processes and programs as well as equity and compensation structures to accommodate the company’s rapid growth. She was also a key member of corporate due diligence teams for a number of PerSeptive acquisitions and was instrumental in the integration and assimilation process for the PE-PerSeptive merger and held an interim Vice President, Human Resources, role at Celera Genomics. Ms. Rader holds a B.S. from Babson College.
back to top
- Carol A. Adiletto, M.S.
Vice President, Clinical and Regulatory Affairs
Ms. Adiletto has 25 years of experience in the medical industry with extensive experience in the in vitro diagnostics (IVD) field in multiple research, product development, clinical, and regulatory roles. Prior to joining BG Medicine, Ms. Adiletto was the Senior Vice President, Clinical & Regulatory Affairs, at WorldCare Clinical, LLC. Ms. Adiletto held senior executive roles including World Wide Vice President Clinical & Regulatory Affairs, for the Cardiac Marker Division of Inverness Medical Innovations, Inc. In addition, Ms. Adiletto held senior level clinical and regulatory positions with Inverness Medical Technology, where she successfully led the activities for market approval of multiple OTC, POC, and professional-use IVD products. Ms. Adiletto served as Director of Clinical Affairs at LifeScan, Inc., after Johnson & Johnson acquired Inverness Medical for $1.3B in 2001. Ms. Adiletto started her career at Instrumentation Laboratory in the fields of clinical chemistry research, product development, and experimental design/statistics. Ms. Adiletto has a B.S. in Medical Laboratory Science and M.S. with Clinical Chemistry Specialization from Northeastern University.
back to top
Aram Adourian, Ph.D.
Vice President, Scientific Affairs
Dr. Adourian joined BG Medicine from the Whitehead Institute for Biomedical Research at the Massachusetts Institute of Technology. While at MIT, he served as Project Manager for Bioinformatics specializing in the development of novel systems and approaches for biomolecular sequencing, analysis and modeling. Dr. Adourian earned his Ph.D. at Harvard University in Statistical Physics, where he was a recipient of the Rudenberg Research Prize, and received his undergraduate degree in Physics from Cornell University.
back to top
Dr. Peter Gardiner
Vice President, Medical Affairs & Chief Medical Officer
Peter brings 25 years of successful experience in the pharmaceutical and medical device industries to BG Medicine. He has held senior roles with DuPont’s Medical Imaging business, Gensia, Inc., GD Searle & Co. Prior to joining BG Medicine, he has served as Medical Director, Global Medical Affairs & Senior Medical Officer for Bristol-Myers Squibb (BMS) Medical Imaging and Vice President, Medical Sciences for the Medical Imaging division. After obtaining his medical degree from Leeds University in the UK, Peter trained in internal medicine and cardiology. Peter is a member of the Royal College of Physicians, United Kingdom, and of the Faculty of Pharmaceutical Medicine.
back to top
Gregg Mayer
Vice President, Diagnostic Strategy
Mr. Mayer joined BG Medicine in May 2007, bringing over 20 years experience as a lifescience executive at leading medical products companies. Most recently, Mr. Mayer was Chief Business Officer at Interleukin Genetics, a developer of specialty genetic tests. Prior to Interleukin, Mr. Mayer was Vice President, Strategic Marketing and Corporate Communications at EPIX Pharmaceuticals, an innovator in magnetic resonance imaging contrast agents, where he managed the company's lead product development program. During his EPIX tenure, Mr. Mayer was elected Chairman of the Medical Imaging Contrast Agent Association and led industry initiatives on U.S. regulatory and reimbursement policy. Before EPIX, Mr. Mayer was Worldwide Marketing Manager, Immunodiagnostics at Chiron Diagnostics (now part of Siemens Medical Solutions Diagnostics) where he planned and managed the development and global launch of more than 30 in vitro diagnostic products in reproductive endocrinology, cardiovascular disease, thyroid function, and other disease areas. He was subsequently U.S. Director of Marketing at Chiron and was responsible for the development and execution of commercial strategy for new immunodiagnostic assays and laboratory systems. Mr. Mayer began his career in sales with Abbott Diagnostics, and eventually joined Abbott's TDx Business Unit where he led portfolio strategy for in vitro transplant immunosuppression and therapeutic drug monitoring diagnostic products. Mr. Mayer holds an M.B.A. from Northwestern University's Kellogg Graduate School of Management and a B.B.A. from The University of Texas at Austin.
back to top
Rene Myers, Ph.D.
Vice President, Strategic Alliances
Dr. Myers came to BG Medicine from Biotage AB (formerly Pyrosequencing) where she was Vice President, Technology and Support. Rene held both scientific and business development roles during her tenure at Biotage and played an integral role in identifying and fostering strategic relationships at key accounts and developing new sales channels into targeted clinical research. Prior, Rene was with Applied Biosystems as a managing scientist on the PNA Research and Development team, Schleicher and Schuell,Inc. as a managing Sr. Scientist and Verigen Inc. She received her Ph.D. from the Ohio State University and a B.S. from Heidelberg College.
back to top
|
